Dublin's stock exchange continued its good progress from yesterday with a 34.91-point rise to stand at 5,738.88 by 11am this morning.

The United States Patent and Trademark Office has issued Neuralab Limited, a subsidiary of Elan, seven patents for the companies' joint research on immunotherapeutic approaches to the prevention and treatment of Alzheimer's disease.

In Dublin today, the ISEQ index closed up 8.44 points at 5415.31.

Elan and Wyeth Pharmaceuticals, a division of Wyeth, today announced that the United States Patent and Trademark Office recently issued Neuralab Limited, a wholly owned subsidiary of Elan, three patents for the companies’ joint research on immunotherapeutic approaches to the treatment of Alzheimer’s disease.